LJPC Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2021-06-04 | 2019 | Lakhmir Chawla, M.D. ( 5) Former Chief Medical Officer | 458,000 | 0 | 0 | 91,600 | 10,611 | 690,544 |
| 2021-06-04 | 2020 | Larry Edwards ( 4) | 208,333 | 0 | 0 | 247,833 | 1,338 | 2,622,950 |
| 2021-06-04 | 2020 | Michael Hearne ( 5) | 78,969 | 0 | 0 | 48,700 | 1,986 | 658,014 |
| 2021-06-04 | 2020 | Dennis Mulroy ( 5) Former Chief Financial Officer | 163,941 | 0 | 0 | 0 | 250,183 | 415,282 |
| 2021-06-04 | 2019 | Dennis Mulroy ( 5) Former Chief Financial Officer | 382,000 | 0 | 0 | 76,400 | 10,739 | 613,087 |
| 2021-06-04 | 2020 | Darryl Wellinghoff ( 5) Former Chief Commercial Officer | 295,095 | 0 | 0 | 249,508 | 117,547 | 676,876 |
| 2021-06-04 | 2019 | Darryl Wellinghoff ( 5) Former Chief Commercial Officer | 315,439 | 0 | 0 | 63,213 | 9,719 | 966,714 |
| 2021-06-04 | 2020 | Lakhmir Chawla, M.D. ( 5) Former Chief Medical Officer | 357,379 | 0 | 0 | 0 | 11,157 | 596,857 |
| 2020-04-29 | 2019 | Dennis Mulroy Chief Financial Officer, Principal Executive Officer and Secretary | 382,000 | 0 | 0 | 76,400 | 10,739 | 613,087 |
| 2020-04-29 | 2018 | Jennifer Carver Former Chief Operating Officer | 405,000 | 0 | 0 | 75,000 | 49,122 | 787,392 |
| 2020-04-29 | 2019 | Jennifer Carver Former Chief Operating Officer | 376,200 | 0 | 0 | 0 | 388,420 | 773,910 |
| 2020-04-29 | 2018 | George Tidmarsh, M.D., Ph.D. Former President, Principal/Chief Executive Officer and Secretary | 589,000 | 0 | 0 | 75,000 | 11,974 | 1,509,081 |
| 2020-04-29 | 2019 | George Tidmarsh, M.D., Ph.D. Former President, Principal/Chief Executive Officer and Secretary | 546,300 | 0 | 0 | 0 | 11,929 | 568,048 |
| 2020-04-29 | 2018 | Darryl Wellinghoff Chief Commercial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020-04-29 | 2019 | Darryl Wellinghoff Chief Commercial Officer | 315,439 | 0 | 0 | 63,213 | 9,719 | 966,714 |
| 2020-04-29 | 2018 | Lakhmir Chawla, M.D. Chief Medical Officer | 444,000 | 0 | 0 | 75,000 | 10,435 | 782,213 |
| 2020-04-29 | 2019 | Lakhmir Chawla, M.D. Chief Medical Officer | 458,000 | 0 | 0 | 91,600 | 10,611 | 690,544 |
| 2020-04-29 | 2018 | Dennis Mulroy Chief Financial Officer, Principal Executive Officer and Secretary | 370,000 | 0 | 0 | 75,000 | 13,188 | 711,586 |
| 2019-09-18 | 2018 | George Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 589,000 | 0 | 0 | 75,000 | 11,974 | 1,509,081 |
| 2019-09-18 | 2017 | Lakhmir Chawla, M.D. Chief Medical Officer | 431,000 | 0 | 0 | 216,000 | 73,497 | 2,175,554 |
| 2019-09-18 | 2018 | Lakhmir Chawla, M.D. Chief Medical Officer | 444,000 | 0 | 0 | 75,000 | 10,435 | 782,213 |
| 2019-09-18 | 2017 | Jennifer Carver Chief Operating Officer | 370,000 | 0 | 0 | 216,000 | 51,159 | 2,092,216 |
| 2019-09-18 | 2018 | Jennifer Carver Chief Operating Officer | 405,000 | 0 | 0 | 75,000 | 49,122 | 787,392 |
| 2019-09-18 | 2017 | George Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 571,000 | 0 | 0 | 428,000 | 18,115 | 6,450,643 |
| 2018-08-22 | 2015 | Dennis M. Mulroy Chief Financial Officer | 236,513 | 0 | 0 | 72,000 | 9,376 | 2,490,733 |
| 2018-08-22 | 2017 | Jennifer A. Carver Chief Operating Officer | 370,000 | 0 | 0 | 216,000 | 51,159 | 2,092,216 |
| 2018-08-22 | 2016 | George F. Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 557,000 | 0 | 0 | 251,000 | 18,148 | 4,653,636 |
| 2018-08-22 | 2015 | George F. Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 525,000 | 0 | 0 | 223,000 | 18,228 | 15,637,928 |
| 2018-08-22 | 2017 | Lakhmir S. Chawla, M.D. Chief Medical Officer | 431,000 | 0 | 0 | 216,000 | 73,497 | 2,175,554 |
| 2018-08-22 | 2016 | Lakhmir S. Chawla, M.D. Chief Medical Officer | 411,500 | 0 | 0 | 132,000 | 40,938 | 1,727,023 |
| 2018-08-22 | 2017 | Dennis M. Mulroy Chief Financial Officer | 359,000 | 0 | 0 | 180,000 | 19,979 | 2,014,036 |
| 2018-08-22 | 2015 | Lakhmir S. Chawla, M.D. Chief Medical Officer | 190,000 | 0 | 0 | 119,000 | 52,588 | 5,552,277 |
| 2018-08-22 | 2016 | Dennis M. Mulroy Chief Financial Officer | 340,000 | 0 | 0 | 110,000 | 17,984 | 1,610,698 |
| 2018-08-22 | 2016 | Jennifer A. Carver Chief Operating Officer | 320,000 | 0 | 0 | 107,000 | 55,381 | 1,625,095 |
| 2018-08-22 | 2017 | James M. Rolke | 350,000 | 0 | 0 | 175,000 | 16,613 | 1,996,670 |
| 2018-08-22 | 2017 | George F. Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 571,000 | 0 | 0 | 428,000 | 18,115 | 6,450,643 |
| 2017-07-31 | 2015 | George F. Tidmarsh, M.D., Ph.D., President, Chief Executive Officer and Secretary | 525,000 | 0 | 0 | 223,000 | 18,228 | 15,637,928 |
| 2017-07-31 | 2014 | George F. Tidmarsh, M.D., Ph.D., President, Chief Executive Officer and Secretary | 470,000 | 0 | 0 | 235,000 | 63,930 | 2,705,909 |
| 2017-07-31 | 2016 | Lakhmir S. Chawla, M.D., Chief Medical Officer | 411,500 | 0 | 0 | 132,000 | 40,938 | 1,727,023 |
| 2017-07-31 | 2015 | Lakhmir S. Chawla, M.D., Chief Medical Officer | 190,000 | 0 | 0 | 119,000 | 52,588 | 5,552,277 |
| 2017-07-31 | 2016 | Dennis M. Mulroy, Chief Financial Officer | 340,000 | 0 | 0 | 110,000 | 17,984 | 1,610,698 |
| 2017-07-31 | 2016 | Jennifer A. Carver, Chief Operating Officer | 320,000 | 0 | 0 | 107,000 | 55,381 | 1,625,095 |
| 2017-07-31 | 2015 | Dennis M. Mulroy, Chief Financial Officer | 236,513 | 0 | 0 | 72,000 | 9,376 | 2,490,733 |
| 2017-07-31 | 2016 | George F. Tidmarsh, M.D., Ph.D., President, Chief Executive Officer and Secretary | 557,000 | 0 | 0 | 251,000 | 18,148 | 4,653,636 |
| 2016-07-22 | 2013 | George F. Tidmarsh, M.D., Ph.D., President, Chief Executive Officer and Secretary | 420,000 | 0 | 0 | 105,000 | 70,827 | 595,827 |
| 2016-07-22 | 2015 | Lakhmir S. Chawla, M.D., Chief Medical Officer | 190,000 | 0 | 0 | 119,000 | 52,588 | 5,552,277 |
| 2016-07-22 | 2015 | Dennis M. Mulroy, Chief Financial Officer | 236,513 | 0 | 0 | 72,000 | 9,376 | 2,490,733 |
| 2016-07-22 | 2015 | George F. Tidmarsh, M.D., Ph.D., President, Chief Executive Officer and Secretary | 525,000 | 0 | 0 | 223,000 | 18,228 | 15,637,928 |
| 2016-07-22 | 2014 | George F. Tidmarsh, M.D., Ph.D., President, Chief Executive Officer and Secretary | 470,000 | 0 | 0 | 235,000 | 63,930 | 2,705,909 |
| 2015-07-20 | 2013 | George F. Tidmarsh, M.D., Ph.D. President and Chief Executive Officer | 420,000 | 0 | 0 | 105,000 | 70,827 | 595,827 |
| 2015-07-20 | 2014 | George F. Tidmarsh, M.D., Ph.D. President and Chief Executive Officer | 470,000 | 0 | 0 | 235,000 | 63,930 | 2,705,909 |
| 2014-07-29 | 2012 | George Tidmarsh, M.D., Ph.D. President and Chief Executive Officer | 226,462 | 0 | 70,826 | 0 | 0 | 30,574,034 |
| 2014-07-29 | 2013 | George Tidmarsh, M.D., Ph.D. President and Chief Executive Officer | 420,000 | 0 | 64,000 | 0 | 0 | 484,000 |
| 2013-05-13 | 2011 | Deirdre Y. Gillespie, M.D. President, Chief Executive Officer and Assistant Secretary | 356,300 | 0 | 0 | 0 | 0 | 356,300 |
| 2013-05-13 | 2012 | Deirdre Y. Gillespie, M.D. President, Chief Executive Officer and Assistant Secretary | 15,600 | 0 | 0 | 0 | 77,778 | 93,378 |
| 2013-05-13 | 2011 | George F. Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
| 2013-05-13 | 2012 | George F. Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 226,462 | 0 | 70,827 | 0 | 0 | 30,644,861 |
| 2012-04-16 | 2011 | George F. Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
| 2012-04-16 | 2011 | Gail A. Sloan Vice President of Finance and Secretary | 192,300 | 0 | 0 | 0 | 0 | 192,300 |
| 2012-04-16 | 2010 | Gail A. Sloan Vice President of Finance and Secretary | 198,551 | 201,860 | 0 | 0 | 0 | 481,051 |
| 2012-04-16 | 2010 | George F. Tidmarsh, M.D., Ph.D. President, Chief Executive Officer and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
| 2012-04-16 | 2011 | Deirdre Y. Gillespie, M.D. President, Chief Executive Officer and Assistant Secretary | 356,300 | 0 | 0 | 0 | 0 | 356,300 |
| 2012-04-16 | 2010 | Deirdre Y. Gillespie, M.D. President, Chief Executive Officer and Assistant Secretary | 405,600 | 608,400 | 0 | 0 | 0 | 1,193,200 |
| 2010-06-25 | 2008 | Former Officers* Niv E. Caviar Executive Vice President, Chief Business | 280,775 | 0 | 0 | 0 | 0 | 643,867 |
| 2010-06-25 | 2008 | Michael Tansey, M.D., Ph.D. Executive Vice President and Chief | 332,875 | 0 | 0 | 0 | 0 | 810,287 |
| 2010-06-25 | 2009 | Gail A. Sloan Vice President of Finance and Secretary | 206,187 | 66,184 | 0 | 0 | 0 | 344,156 |
| 2010-06-25 | 2008 | Current Officers Deirdre Y. Gillespie, M.D. President, Chief Executive Officer and | 402,600 | 0 | 0 | 0 | 0 | 1,697,135 |
| 2010-06-25 | 2009 | Current Officers Deirdre Y. Gillespie, M.D. President, Chief Executive Officer and | 421,200 | 202,800 | 0 | 0 | 0 | 1,791,161 |
| 2010-06-25 | 2009 | Former Officers* Niv E. Caviar Executive Vice President, Chief Business | 124,734 | 211,612 | 0 | 0 | 0 | 971,799 |
| 2010-06-25 | 2008 | Gail A. Sloan Vice President of Finance and Secretary | 196,906 | 0 | 0 | 0 | 0 | 557,998 |
| 2010-06-25 | 2009 | Michael Tansey, M.D., Ph.D. Executive Vice President and Chief | 113,402 | 251,063 | 0 | 0 | 0 | 936,715 |
| 2008-04-11 | 2007 | Josefina T. Elchico Vice President of Quality Operations | 206,895 | 0 | 0 | 31,209 | 0 | 492,721 |
| 2008-04-11 | 2007 | Deirdre Y. Gillespie, M.D. President, Chief Executive Officer and Assistant Secretary | 387,115 | 0 | 0 | 73,125 | 0 | 1,477,116 |
| 2008-04-11 | 2006 | Deirdre Y. Gillespie, M.D. President, Chief Executive Officer and Assistant Secretary | 292,789 | 50,000 | 0 | 131,250 | 61,770 | 1,263,681 |
| 2008-04-11 | 2007 | Niv E. Caviar Executive Vice President, Chief Business & Financial Officer | 171,346 | 0 | 0 | 23,461 | 35,000 | 361,311 |
| 2008-04-11 | 2007 | Michael Tansey, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 325,000 | 0 | 0 | 48,750 | 0 | 622,369 |
| 2008-04-11 | 2006 | Michael Tansey, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 95,733 | 0 | 0 | 22,484 | 0 | 180,328 |
| 2008-04-11 | 2007 | Gail A. Sloan Vice President of Finance and Secretary | 187,505 | 0 | 0 | 21,375 | 0 | 541,081 |
| 2008-04-11 | 2006 | Gail A. Sloan Vice President of Finance and Secretary | 177,023 | 44,256 | 0 | 37,175 | 0 | 571,713 |
| 2008-04-11 | 2006 | Josefina T. Elchico Vice President of Quality Operations | 202,000 | 50,500 | 0 | 31,815 | 0 | 486,443 |
| 2007-04-13 | 2006 | Theodora Reilly Former Vice President of Human Resources | 79,079 | 46,469 | 0 | 0 | 185,874 | 529,860 |
| 2007-04-13 | 2006 | Bruce K. Bennett, Jr. Former Vice President of Manufacturing | 87,401 | 52,462 | 0 | 0 | 209,847 | 581,992 |
| 2007-04-13 | 2006 | Steven B. Engle Former Chief Executive Officer and Former Chairman of the Board | 146,160 | 0 | 96,278 | 0 | 957,415 | 2,099,303 |
| 2007-04-13 | 2006 | Paul C. Jenn, Ph.D. Vice President of Product Development | 196,962 | 0 | 43,414 | 31,022 | 0 | 541,565 |
| 2007-04-13 | 2006 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President | 305,482 | 0 | 67,333 | 52,390 | 0 | 950,048 |
| 2007-04-13 | 2006 | Josefina T. Elchico Vice President of Quality Operations | 202,000 | 50,500 | 0 | 31,815 | 0 | 486,443 |
| 2007-04-13 | 2006 | Gail A. Sloan Vice President of Finance and Secretary | 177,023 | 44,256 | 0 | 37,175 | 0 | 571,713 |
| 2007-04-13 | 2006 | Deirdre Y. Gillespie, M.D. President and Chief Executive Officer | 292,789 | 50,000 | 0 | 131,250 | 61,770 | 1,263,681 |
| 2006-04-07 | 2003 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 275,445 | 77,035 | 0 | 0 | 0 | 352,480 |
| 2006-04-07 | 2004 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 290,577 | 87,998 | 0 | 0 | 0 | 378,575 |
| 2006-04-07 | 2005 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 302,785 | 165,333 | 0 | 0 | 0 | 468,118 |
| 2006-04-07 | 2003 | Steven B. Engle Former Chief Executive Officer and Former Chairman of the Board | 392,798 | 140,664 | 0 | 0 | 0 | 533,462 |
| 2006-04-07 | 2004 | Steven B. Engle Former Chief Executive Officer and Former Chairman of the Board | 418,855 | 144,474 | 0 | 0 | 0 | 563,329 |
| 2006-04-07 | 2005 | Steven B. Engle Former Chief Executive Officer and Former Chairman of the Board | 434,209 | 262,209 | 0 | 0 | 0 | 696,418 |
| 2006-04-07 | 2003 | Deirdre Y. Gillespie, M.D. President and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2006-04-07 | 2003 | Josefina T. Elchico Vice President of Quality Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| 2006-04-07 | 2005 | Deirdre Y. Gillespie, M.D. President and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2006-04-07 | 2004 | Deirdre Y. Gillespie, M.D. President and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2006-04-07 | 2005 | Paul C. Jenn, Ph.D. Vice President of Product Development | 195,811 | 105,276 | 0 | 0 | 0 | 301,087 |
| 2006-04-07 | 2004 | Paul C. Jenn, Ph.D. Vice President of Product Development | 188,711 | 49,120 | 0 | 0 | 0 | 237,831 |
| 2006-04-07 | 2003 | Paul C. Jenn, Ph.D. Vice President of Product Development | 177,108 | 49,867 | 0 | 0 | 0 | 226,975 |
| 2006-04-07 | 2005 | Josefina T. Elchico Vice President of Quality Operations | 203,284 | 71,535 | 0 | 0 | 0 | 274,819 |
| 2006-04-07 | 2004 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 201,065 | 52,302 | 0 | 0 | 0 | 253,367 |
| 2006-04-07 | 2004 | Josefina T. Elchico Vice President of Quality Operations | 41,887 | 528 | 0 | 0 | 0 | 42,415 |
| 2006-04-07 | 2005 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 208,629 | 94,877 | 0 | 0 | 0 | 303,506 |
| 2005-10-27 | 2003 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 392,798 | 140,664 | 0 | 0 | 0 | 533,462 |
| 2005-10-27 | 2002 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 251,158 | 40,661 | 0 | 0 | 0 | 291,819 |
| 2005-10-27 | 2003 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 275,445 | 77,035 | 0 | 0 | 0 | 352,480 |
| 2005-10-27 | 2004 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 290,577 | 87,998 | 0 | 0 | 0 | 378,575 |
| 2005-10-27 | 2002 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 374,946 | 77,406 | 0 | 0 | 0 | 452,352 |
| 2005-10-27 | 2004 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 418,855 | 144,474 | 0 | 0 | 0 | 563,329 |
| 2005-10-27 | 2002 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 158,823 | 458 | 0 | 0 | 25,000 | 184,281 |
| 2005-10-27 | 2002 | William J. Welch Vice President of Sales and Marketing | 193,091 | 31,181 | 0 | 0 | 0 | 224,272 |
| 2005-10-27 | 2003 | William J. Welch Vice President of Sales and Marketing | 212,827 | 57,189 | 0 | 0 | 0 | 270,016 |
| 2005-10-27 | 2004 | William J. Welch Vice President of Sales and Marketing | 233,184 | 60,743 | 0 | 0 | 0 | 293,927 |
| 2005-10-27 | 2003 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 275,050 | 54,195 | 0 | 0 | 0 | 329,245 |
| 2005-10-27 | 2004 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 289,401 | 75,190 | 0 | 0 | 0 | 364,591 |
| 2005-10-27 | 2002 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 170,731 | 458 | 0 | 0 | 0 | 171,189 |
| 2005-10-27 | 2003 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 188,269 | 52,567 | 0 | 0 | 0 | 240,836 |
| 2005-10-27 | 2004 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 201,065 | 52,302 | 0 | 0 | 0 | 253,367 |
| 2005-04-11 | 2004 | William J. Welch Vice President of Sales and Marketing | 233,184 | 60,743 | 0 | 0 | 0 | 293,927 |
| 2005-04-11 | 2003 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 275,445 | 77,035 | 0 | 0 | 0 | 352,480 |
| 2005-04-11 | 2002 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 251,158 | 40,661 | 0 | 0 | 0 | 291,819 |
| 2005-04-11 | 2004 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 201,065 | 52,302 | 0 | 0 | 0 | 253,367 |
| 2005-04-11 | 2003 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 188,269 | 52,567 | 0 | 0 | 0 | 240,836 |
| 2005-04-11 | 2002 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 170,731 | 458 | 0 | 0 | 0 | 171,189 |
| 2005-04-11 | 2004 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 289,401 | 75,190 | 0 | 0 | 0 | 364,591 |
| 2005-04-11 | 2002 | William J. Welch Vice President of Sales and Marketing | 193,091 | 31,181 | 0 | 0 | 0 | 224,272 |
| 2005-04-11 | 2003 | William J. Welch Vice President of Sales and Marketing | 212,827 | 57,189 | 0 | 0 | 0 | 270,016 |
| 2005-04-11 | 2004 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 418,855 | 144,474 | 0 | 0 | 0 | 563,329 |
| 2005-04-11 | 2003 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 392,798 | 140,664 | 0 | 0 | 0 | 533,462 |
| 2005-04-11 | 2002 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 374,946 | 77,406 | 0 | 0 | 0 | 452,352 |
| 2005-04-11 | 2004 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 290,577 | 87,998 | 0 | 0 | 0 | 378,575 |
| 2005-04-11 | 2003 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 275,050 | 54,195 | 0 | 0 | 0 | 329,245 |
| 2005-04-11 | 2002 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 158,823 | 458 | 0 | 0 | 25,000 | 184,281 |
| 2004-04-14 | 2001 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 0 | 0 | 0 | 0 | 0 | 0 |
| 2004-04-14 | 2003 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 392,798 | 140,664 | 0 | 0 | 0 | 533,462 |
| 2004-04-14 | 2002 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 374,946 | 77,406 | 0 | 0 | 0 | 452,352 |
| 2004-04-14 | 2001 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 345,655 | 109,252 | 0 | 0 | 0 | 454,907 |
| 2004-04-14 | 2003 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 275,445 | 77,035 | 0 | 0 | 0 | 352,480 |
| 2004-04-14 | 2002 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 251,158 | 40,661 | 0 | 0 | 0 | 291,819 |
| 2004-04-14 | 2001 | Matthew D. Linnik, Ph.D. Chief Scientific Officer and Executive Vice President of | 203,400 | 57,456 | 0 | 0 | 0 | 260,856 |
| 2004-04-14 | 2003 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 188,269 | 52,567 | 0 | 0 | 0 | 240,836 |
| 2004-04-14 | 2002 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 170,731 | 458 | 0 | 0 | 0 | 171,189 |
| 2004-04-14 | 2001 | Bruce K. Bennett, Jr. Vice President of Manufacturing | 0 | 0 | 0 | 0 | 0 | 0 |
| 2004-04-14 | 2003 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 275,050 | 54,195 | 0 | 0 | 0 | 329,245 |
| 2004-04-14 | 2002 | Kenneth R. Heilbrunn, M.D. Vice President of Clinical Development | 158,823 | 458 | 0 | 0 | 25,000 | 184,281 |
| 2004-04-14 | 2003 | William J. Welch Vice President of Sales and Marketing | 212,827 | 57,189 | 0 | 0 | 0 | 270,016 |
| 2004-04-14 | 2002 | William J. Welch Vice President of Sales and Marketing | 193,091 | 31,181 | 0 | 0 | 0 | 224,272 |
| 2004-04-14 | 2001 | William J. Welch Vice President of Sales and Marketing | 114,323 | 375 | 0 | 0 | 43,516 | 158,214 |
| 2003-04-11 | 2002 | Kenneth R. Heilbrunn, M.D. | 158,823 | 458 | 0 | 0 | 0 | 159,281 |
| 2003-04-11 | 2002 | Paul C. Jenn, Ph.D. | 167,705 | 26,231 | 0 | 0 | 0 | 193,936 |
| 2003-04-11 | 2002 | William J. Welch | 193,091 | 31,181 | 0 | 0 | 0 | 224,272 |
| 2003-04-11 | 2002 | Matthew D. Linnik, Ph.D. | 251,158 | 40,661 | 0 | 0 | 0 | 291,819 |
| 2003-04-11 | 2002 | Steven B. Engle | 374,946 | 77,406 | 0 | 0 | 0 | 452,352 |
| 2002-04-11 | 2000 | Andrew Wiseman, Ph.D. Senior Director of Business Development and Investor Relations | 121,908 | 17,634 | 0 | 0 | 0 | 139,542 |
| 2002-04-11 | 2001 | Andrew Wiseman, Ph.D. Senior Director of Business Development and Investor Relations | 131,810 | 24,977 | 0 | 0 | 0 | 156,787 |
| 2002-04-11 | 1999 | Paul C. Jenn, Ph.D. Vice President of Product Development | 111,709 | 876 | 0 | 0 | 0 | 112,585 |
| 2002-04-11 | 2000 | Paul C. Jenn, Ph.D. Vice President of Product Development | 125,744 | 18,376 | 0 | 0 | 0 | 144,120 |
| 2002-04-11 | 2001 | Paul C. Jenn, Ph.D. Vice President of Product Development | 150,230 | 24,988 | 0 | 0 | 0 | 175,218 |
| 2002-04-11 | 1999 | William J. Welch | 104,744 | 21,608 | 0 | 0 | 0 | 126,352 |
| 2002-04-11 | 2001 | William J. Welch | 114,323 | 375 | 0 | 0 | 43,516 | 158,214 |
| 2002-04-11 | 1999 | Matthew D. Linnik, Ph.D. Executive Vice President of Research | 161,334 | 30,389 | 0 | 0 | 0 | 191,723 |
| 2002-04-11 | 2000 | Matthew D. Linnik, Ph.D. Executive Vice President of Research | 188,522 | 45,390 | 0 | 0 | 0 | 233,912 |
| 2002-04-11 | 2001 | Matthew D. Linnik, Ph.D. Executive Vice President of Research | 203,400 | 57,456 | 0 | 0 | 0 | 260,856 |
| 2002-04-11 | 1999 | Andrew Wiseman, Ph.D. Senior Director of Business Development and Investor Relations | 107,656 | 884 | 0 | 0 | 0 | 108,540 |
| 2002-04-11 | 1999 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 286,347 | 63,691 | 0 | 0 | 0 | 350,038 |
| 2002-04-11 | 2000 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 307,013 | 95,700 | 0 | 0 | 0 | 402,713 |
| 2002-04-11 | 2001 | Steven B. Engle Chief Executive Officer and Chairman of the Board | 345,655 | 109,252 | 0 | 0 | 0 | 454,907 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
